Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 298

    1.

    Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.

    Sackmann-Sala L, Ding J, Frohman LA, Kopchick JJ.

    Growth Horm IGF Res. 2009 Dec;19(6):471-7. Epub 2009 Apr 21.PMID: 19386527 [PubMed - in process]Related articles

    2.

    Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.

    Luque RM, Soares BS, Peng XD, Krishnan S, Cordoba-Chacon J, Frohman LA, Kineman RD.

    Endocrinology. 2009 Jul;150(7):3177-85. Epub 2009 Apr 2.PMID: 19342460 [PubMed - indexed for MEDLINE]Related articles

    3.

    Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.

    Boscaro M, Ludlam WH, Atkinson B, Glusman JE, Petersenn S, Reincke M, Snyder P, Tabarin A, Biller BM, Findling J, Melmed S, Darby CH, Hu K, Wang Y, Freda PU, Grossman AB, Frohman LA, Bertherat J.

    J Clin Endocrinol Metab. 2009 Jan;94(1):115-22. Epub 2008 Oct 28.PMID: 18957506 [PubMed - indexed for MEDLINE]Related articles

    4.

    The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.

    Leontiou CA, Gueorguiev M, van der Spuy J, Quinton R, Lolli F, Hassan S, Chahal HS, Igreja SC, Jordan S, Rowe J, Stolbrink M, Christian HC, Wray J, Bishop-Bailey D, Berney DM, Wass JA, Popovic V, Ribeiro-Oliveira A Jr, Gadelha MR, Monson JP, Akker SA, Davis JR, Clayton RN, Yoshimoto K, Iwata T, Matsuno A, Eguchi K, Musat M, Flanagan D, Peters G, Bolger GB, Chapple JP, Frohman LA, Grossman AB, Korbonits M.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2390-401. Epub 2008 Apr 1.PMID: 18381572 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Normal physiology of hypothalamic pituitary regulation.

    Sam S, Frohman LA.

    Endocrinol Metab Clin North Am. 2008 Mar;37(1):1-22, vii. Review.PMID: 18226728 [PubMed - indexed for MEDLINE]Related articles

    6.

    The empty sella.

    Naing S, Frohman LA.

    Pediatr Endocrinol Rev. 2007 Jun;4(4):335-42. Review.PMID: 17643081 [PubMed - indexed for MEDLINE]Related articles

    7.

    Pituitary tumor enlargement in two patients with acromegaly during pegvisomant therapy.

    Frohman LA, Bonert V.

    Pituitary. 2007;10(3):283-9.PMID: 17534717 [PubMed - indexed for MEDLINE]Related articles

    8.

    Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.

    Ionescu M, Frohman LA.

    J Clin Endocrinol Metab. 2006 Dec;91(12):4792-7. Epub 2006 Oct 3.PMID: 17018654 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Once-daily administration of CJC-1295, a long-acting growth hormone-releasing hormone (GHRH) analog, normalizes growth in the GHRH knockout mouse.

    Alba M, Fintini D, Sagazio A, Lawrence B, Castaigne JP, Frohman LA, Salvatori R.

    Am J Physiol Endocrinol Metab. 2006 Dec;291(6):E1290-4. Epub 2006 Jul 5.PMID: 16822960 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.

    Teichman SL, Neale A, Lawrence B, Gagnon C, Castaigne JP, Frohman LA.

    J Clin Endocrinol Metab. 2006 Mar;91(3):799-805. Epub 2005 Dec 13.PMID: 16352683 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Consensus statement: medical management of acromegaly.

    Melmed S, Casanueva F, Cavagnini F, Chanson P, Frohman LA, Gaillard R, Ghigo E, Ho K, Jaquet P, Kleinberg D, Lamberts S, Laws E, Lombardi G, Sheppard MC, Thorner M, Vance ML, Wass JA, Giustina A.

    Eur J Endocrinol. 2005 Dec;153(6):737-40.PMID: 16322377 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.

    Park S, Peng XD, Frohman LA, Kineman RD.

    Neuroendocrinology. 2005;81(6):360-71. Epub 2005 Oct 18.PMID: 16244497 [PubMed - indexed for MEDLINE]Related articles

    13.

    Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas.

    Soares BS, Eguchi K, Frohman LA.

    J Clin Endocrinol Metab. 2005 Dec;90(12):6580-7. Epub 2005 Sep 27.PMID: 16189251 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    p130Rb2 and p27kip1 cooperate to control mobilization of angiogenic progenitors from the bone marrow.

    Vidal A, Zacharoulis S, Guo W, Shaffer D, Giancotti F, Bramley AH, de la Hoz C, Jensen KK, Kato D, MacDonald DD, Knowles J, Yeh N, Frohman LA, Rafii S, Lyden D, Koff A.

    Proc Natl Acad Sci U S A. 2005 May 10;102(19):6890-5. Epub 2005 May 2.PMID: 15867156 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Isolated familial somatotropinoma.

    Soares BS, Frohman LA.

    Pituitary. 2004;7(2):95-101.PMID: 15761658 [PubMed - indexed for MEDLINE]Related articles

    16.

    Familial acromegaly.

    Frohman LA, Eguchi K.

    Growth Horm IGF Res. 2004 Jun;14 Suppl A:S90-6. Review.PMID: 15135786 [PubMed - indexed for MEDLINE]Related articles

    17.

    A meiotic recombination in a new isolated familial somatotropinoma kindred.

    Luccio-Camelo DC, Une KN, Ferreira RE, Khoo SK, Nickolov R, Bronstein MD, Vaisman M, Teh BT, Frohman LA, Mendonça BB, Gadelha MR.

    Eur J Endocrinol. 2004 May;150(5):643-8.PMID: 15132719 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Diagnosis and treatment of acromegaly complications.

    Giustina A, Casanueva FF, Cavagnini F, Chanson P, Clemmons D, Frohman LA, Gaillard R, Ho K, Jaquet P, Kleinberg DL, Lamberts SW, Lombardi G, Sheppard M, Strasburger CJ, Vance ML, Wass JA, Melmed S; Pituitary Society and the European Neuroendocrine Association.

    J Endocrinol Invest. 2003 Dec;26(12):1242-7.PMID: 15055479 [PubMed - indexed for MEDLINE]Related articles

    19.

    Isolated familial somatotropinomas: clinical and genetic considerations.

    Frohman LA.

    Trans Am Clin Climatol Assoc. 2003;114:165-77.PMID: 12813918 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Growth hormone-releasing hormone and pituitary somatotrope proliferation.

    Frohman LA, Kineman RD.

    Minerva Endocrinol. 2002 Dec;27(4):277-85. Review.PMID: 12511850 [PubMed - indexed for MEDLINE]Related articles

    21.

    Who needs growth hormone therapy? Growth hormone helps some, but its use as an "anti-aging" agent is dubious.

    Frohman LA.

    Health News. 2002 Oct;8(10):4. No abstract available. PMID: 12416482 [PubMed - indexed for MEDLINE]Related articles

    22.

    Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis.

    Frohman LA, Kineman RD.

    Trends Endocrinol Metab. 2002 Sep;13(7):299-303. Review.PMID: 12163232 [PubMed - indexed for MEDLINE]Related articles

    23.

    Controversy about treatment of growth hormone-deficient adults: a commentary.

    Frohman LA.

    Ann Intern Med. 2002 Aug 6;137(3):202-4. No abstract available. PMID: 12160369 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.

    Kineman RD, Teixeira LT, Amargo GV, Coschigano KT, Kopchick JJ, Frohman LA.

    Endocrinology. 2001 Sep;142(9):3764-73.PMID: 11517152 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Authors' Response: Isolated Familial Somatotropinomas: Does the Disease Map to 11q13 or to 2p16?

    Gadelha MR, Rhode K, Kineman RD, Frohman LA.

    J Clin Endocrinol Metab. 2000 Dec;85(12):4921. No abstract available. PMID: 11134166 [PubMed - as supplied by publisher]Related articles

    27.

    Secretagogues and the somatotrope: signaling and proliferation.

    Frohman LA, Kineman RD, Kamegai J, Park S, Teixeira LT, Coschigano KT, Kopchic JJ.

    Recent Prog Horm Res. 2000;55:269-90; discussion 290-1. Review.PMID: 11036941 [PubMed - indexed for MEDLINE]Related articles

    28.

    Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis.

    Park S, Kamegai J, Johnson TA, Frohman LA, Kineman RD.

    Endocrinology. 2000 Oct;141(10):3556-63.PMID: 11014208 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Glucocorticoids regulate pituitary growth hormone secretagogue receptor gene expression.

    Tamura H, Kamegai J, Sugihara H, Kineman RD, Frohman LA, Wakabayashi I.

    J Neuroendocrinol. 2000 Jun;12(6):481-5.PMID: 10844575 [PubMed - indexed for MEDLINE]Related articles

    30.

    p27Kip1-deficient mice exhibit accelerated growth hormone-releasing hormone (GHRH)-induced somatotrope proliferation and adenoma formation.

    Teixeira LT, Kiyokawa H, Peng XD, Christov KT, Frohman LA, Kineman RD.

    Oncogene. 2000 Apr 6;19(15):1875-84.PMID: 10773877 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Increase in mRNA concentrations of pituitary receptors for growth hormone-releasing hormone and growth hormone secretagogues after neonatal monosodium glutamate treatment.

    Kovacs M, Kineman RD, Schally AV, Flerko B, Frohman LA.

    J Neuroendocrinol. 2000 Apr;12(4):335-41.PMID: 10718930 [PubMed - indexed for MEDLINE]Related articles

    32.

    Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12.

    Gadelha MR, Une KN, Rohde K, Vaisman M, Kineman RD, Frohman LA.

    J Clin Endocrinol Metab. 2000 Feb;85(2):707-14.PMID: 10690880 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.

    Kamegai J, Wakabayashi I, Kineman RD, Frohman LA.

    J Neuroendocrinol. 1999 Apr;11(4):299-306.PMID: 10223284 [PubMed - indexed for MEDLINE]Related articles

    35.

    Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.

    Gadelha MR, Prezant TR, Une KN, Glick RP, Moskal SF 2nd, Vaisman M, Melmed S, Kineman RD, Frohman LA.

    J Clin Endocrinol Metab. 1999 Jan;84(1):249-56.PMID: 9920092 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Role of growth hormone (GH)-releasing hormone and somatostatin on leptin-induced GH secretion.

    Carro E, Señarís RM, Seoane LM, Frohman LA, Arimura A, Casanueva FF, Diéguez C.

    Neuroendocrinology. 1999 Jan;69(1):3-10.PMID: 9892845 [PubMed - indexed for MEDLINE]Related articles

    37.

    Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf Rat.

    Kamegai J, Wakabayashi I, Miyamoto K, Unterman TG, Kineman RD, Frohman LA.

    Neuroendocrinology. 1998 Nov;68(5):312-8.PMID: 9822798 [PubMed - indexed for MEDLINE]Related articles

    39.

    Expression of a fusion gene consisting of the mouse growth hormone-releasing hormone gene promoter linked to the SV40 T-antigen gene in transgenic mice.

    Nogues N, Magnan E, De Grandis P, Butz M, Kineman RD, Kopchick JJ, Frohman LA.

    Mol Cell Endocrinol. 1998 Feb;137(2):161-8.PMID: 9605518 [PubMed - indexed for MEDLINE]Related articles

    40.

    Acromegaly and Cushing's syndrome due to ectopic production of GHRH and ACTH by a thymic carcinoid tumour: in vitro responses to GHRH and GHRP-6.

    Jansson JO, Svensson J, Bengtsson BA, Frohman LA, Ahlman H, Wängberg B, Nilsson O, Nilsson M.

    Clin Endocrinol (Oxf). 1998 Feb;48(2):243-50.PMID: 9579239 [PubMed - indexed for MEDLINE]Related articles

    41.
    42.

    Homologous down-regulation of growth hormone-releasing hormone receptor messenger ribonucleic acid levels.

    Aleppo G, Moskal SF 2nd, De Grandis PA, Kineman RD, Frohman LA.

    Endocrinology. 1997 Mar;138(3):1058-65.PMID: 9048609 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.

    Jaffe CA, DeMott-Friberg R, Frohman LA, Barkan AL.

    J Clin Endocrinol Metab. 1997 Feb;82(2):634-7.PMID: 9024267 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    New insights into the regulation of somatotrope function using genetic and transgenic models.

    Frohman LA.

    Metabolism. 1996 Aug;45(8 Suppl 1):1-3. Review.PMID: 8769367 [PubMed - indexed for MEDLINE]Related articles

    46.

    Growth hormone physiology in health and disease: insights using genetic and transgenic models.

    Frohman LA.

    J Pediatr Endocrinol Metab. 1996 Jun;9 Suppl 3:233-6. Review. No abstract available. PMID: 8887166 [PubMed - indexed for MEDLINE]Related articles

    47.

    Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1).

    Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A.

    Cell. 1996 May 31;85(5):721-32.PMID: 8646780 [PubMed - indexed for MEDLINE]Related articles

    48.

    Acromegaly: what constitutes optimal therapy?

    Frohman LA.

    J Clin Endocrinol Metab. 1996 Feb;81(2):443-5. Review. No abstract available. PMID: 8636245 [PubMed - indexed for MEDLINE]Related articles

    49.

    Autofeedback suppression of growth hormone (GH) secretion in transgenic mice expressing a human GH reporter targeted by tyrosine hydroxylase 5'-flanking sequences to the hypothalamus.

    Szabo M, Butz MR, Banerjee SA, Chikaraishi DM, Frohman LA.

    Endocrinology. 1995 Sep;136(9):4044-8.PMID: 7649113 [PubMed - indexed for MEDLINE]Related articles

    50.

    Discordant effects of endogenous and exogenous somatostatin on growth hormone-releasing hormone secretion from perifused mouse hypothalami.

    Pecori Giraldi F, Frohman LA.

    Neuroendocrinology. 1995 May;61(5):566-72.PMID: 7617135 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...